Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine

NCT03028116 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: influenza vaccine
BIOLOGICAL: Placebo

Sponsor

Research Institute for Biological Safety Problems

Collaborators

[object Object]
[object Object]